UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

The New England journal of medicine, 2020-03, Vol.382 (12), p.1112-1123

2020

Volltextzugriff (PDF)

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Journal of acquired immune deficiency syndromes (1999), 2020-12, Vol.85 (4), p.498-506

2020

Volltextzugriff (PDF)

The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?

Journal of the International Association of Providers of AIDS Care, 2021-01, Vol.20, p.23259582211009011-23259582211009011

2021

Volltextzugriff (PDF)

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

The New England journal of medicine, 2011-10, Vol.365 (16), p.1482-1491

2011

Volltextzugriff (PDF)

Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

AIDS (London), 2018-03, Vol.32 (6), p.761-765

2018

Volltextzugriff (PDF)

Determinants of facilitated health insurance enrollment for patients with HIV disease, and impact of insurance enrollment on targeted health outcomes

BMC infectious diseases, 2018-03, Vol.18 (1), p.132-132, Article 132

2018

Volltextzugriff (PDF)

High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis

The Pediatric infectious disease journal, 2022-05, Vol.41 (5), p.e194-e202

2022

Volltextzugriff (PDF)

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

BMC health services research, 2021-03, Vol.21 (1), p.255-255, Article 255

2021

Volltextzugriff (PDF)

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study

Clinical infectious diseases, 2013-08, Vol.57 (4), p.586-593

2013

Volltextzugriff (PDF)

Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV

PloS one, 2018-11, Vol.13 (11), p.e0207372-e0207372

2018

Volltextzugriff (PDF)

A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary Outcomes

Journal of the International Association of Providers of AIDS Care, 2021-01, Vol.20, p.232595822110414-23259582211041423

2021

Volltextzugriff (PDF)

Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults

NeuroImage clinical, 2018-01, Vol.20, p.85-91

2018

Volltextzugriff (PDF)

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

BMC infectious diseases, 2021-02, Vol.21 (1), p.205-10, Article 205

2021

Volltextzugriff (PDF)

Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV

NeuroImage clinical, 2021-01, Vol.31, p.102775, Article 102775

2021

Volltextzugriff (PDF)

The age-related trajectory of visual attention neural function is altered in adults living with HIV: A cross-sectional MEG study

EBioMedicine, 2020-11, Vol.61, p.103065-103065, Article 103065

2020

Volltextzugriff (PDF)

Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain

PloS one, 2013-06, Vol.8 (6), p.e66241

2013

Volltextzugriff (PDF)

Long-acting drugs and formulations for the treatment and prevention of HIV infection

International journal of antimicrobial agents, 2021-01, Vol.57 (1), p.106220-106220, Article 106220

2021

Volltextzugriff (PDF)

Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (37), p.15001-15005

2012

Volltextzugriff (PDF)

Neuroinflammatory profiles regulated by the redox environment predicted cognitive dysfunction in people living with HIV: A cross-sectional study

EBioMedicine, 2021-08, Vol.70, p.103487, Article 103487

2021

Volltextzugriff (PDF)

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction

BMC infectious diseases, 2018-07, Vol.18 (1), p.310-310, Article 310

2018

Volltextzugriff (PDF)

Current strategies to treat tuberculosis [version 1; peer review: 2 approved]

F1000 research, 2016, Vol.5, p.2579

2016

Volltextzugriff (PDF)

Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial

The Lancet. Microbe, 2020-06, Vol.1 (2), p.e84-e92

2020

Volltextzugriff (PDF)

New and Noteworthy in Tuberculosis Diagnostics and Treatment

Topics in antiviral medicine, 2018-06, Vol.26 (2), p.58-61

Swindells, Susan

2018

Volltextzugriff (PDF)

Adherence of Human Immunodeficiency Virus—Infected Patients to Antiretroviral Therapy

Clinical infectious diseases, 1999-10, Vol.29 (4), p.824-830

1999

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(198)

Publikationsform

Sprache

Englisch
(251)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

Determinants of facilitated health insurance enrollment for patients with HIV disease, and impact of insurance enrollment on targeted health outcomes

High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study

Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV

Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary Outcomes

Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV

The age-related trajectory of visual attention neural function is altered in adults living with HIV: A cross-sectional MEG study

Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain

Long-acting drugs and formulations for the treatment and prevention of HIV infection

Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide

Neuroinflammatory profiles regulated by the redox environment predicted cognitive dysfunction in people living with HIV: A cross-sectional study

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction

Current strategies to treat tuberculosis [version 1; peer review: 2 approved]

Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial

New and Noteworthy in Tuberculosis Diagnostics and Treatment

Adherence of Human Immunodeficiency Virus—Infected Patients to Antiretroviral Therapy

Suchergebnisse filtern